• 1
    Suter PF. Lower airway and pulmonary parenchymal diseases, In: SuterPF. ed. Thoracic Radiography: A Text Atlas of Thoracic Diseases of the Dog and Cat. Basel, Switzerland: Wettswil; 1984, pp. 517682.
  • 2
    Sedlmeier H, Dahme E. Pulmonary circulatory abnormalities, In: DobbersteinE, PallaskeG, StunziH. eds. Handbuch der Speziellen Pathologischen Anatomie der Haustiere, 3rd ed. Berlin: Paul Parey; 1962, pp. 148157.
  • 3
    Johnson LR, Lappin R, Baker DC. Pulmonary thromboembolism in 29 dogs: 1985–1995. J Vet Intern Med 1999; 13 (4):338345.
  • 4
    Norris CR, Griffey SM, Samii VF. Pulmonary thromboembolism in cats: 29 cases (1987–1997). J Am Vet Med Assoc 1999; 215 (11):16501654.
  • 5
    Schermerhorn T, Pembleton-Corbett JR, Kornreich B. Pulmonary thromboembolism in cats. J Vet Intern Med 2004; 18 (4):533535.
  • 6
    Moser KM, Guisan M, Bartimmo EE, et al. In vivo and post mortem dissolution rates of pulmonary emboli and venous thrombi in the dog. Circulation 1973; 48 (1):170178.
  • 7
    Lang IM, Marsh JJ, Konopka RG, et al. Factors contributing to increased vascular fibrinolytic-activity in mongrel dogs. Circulation 1993; 87 (6):19902000.
  • 8
    Palmer KG, King LG, Van Winkle TJ. Clinical manifestations and associated disease syndromes in dogs with cranial vena cava thrombosis: 17 cases (1989–1996). J Am Vet Med Assoc 1998; 213 (2):220224.
  • 9
    Van Winkle TJ, Bruce E. Thrombosis of the portal vein in eleven dogs. Vet Pathol 1993; 30 (1):2835.
  • 10
    Hargis AM, Stephens LC, Benjamin SA, et al. Relationship of hypothyroidism to diabetes mellitus, renal amyloidosis, and thrombosis in purebred beagles. Am J Vet Res 1981; 42 (6):10771081.
  • 11
    Keith JC Jr, Rawlings CA, Schaub RG. Pulmonary thromboembolism during therapy of dirofilariasis with thiacetarsamide: modification with aspirin or prednisolone. Am J Vet Res 1983; 44 (7):12781283.
  • 12
    LaRue MJ, Murtaugh RJ. Pulmonary thromboembolism in dogs – 47 cases (1986–1987). J Am Vet Med Assoc 1990; 197 (10):13681372.
  • 13
    Burns MG, Kelly AB, Hornof WJ, et al. Pulmonary artery thrombosis in three dogs with hyperadrenocorticism. J Am Vet Med Assoc 1981; 178 (4):388393.
  • 14
    Hardie EM, Vaden SL, Spaulding K, et al. Splenic infarction in 16 dogs: a retrospective study. J Vet Intern Med 1995; 9 (3):141148.
  • 15
    Bunch SE, Metcalf MR, Crane SW, et al. Idiopathic pleural effusion and pulmonary thromboembolism in a dog with autoimmune hemolytic-anemia. J Am Vet Med Assoc 1989; 195 (12):17481753.
  • 16
    Klein MK, Dow SW, Rosychuk RA. Pulmonary thromboembolism associated with immune-mediated hemolytic anemia in dogs: ten cases (1982–1987). J Am Vet Med Assoc 1989; 195 (2):246250.
  • 17
    Di Bartola SP, Meuten DJ. Renal amyloidosis in 2 dogs presented for thromboembolic phenomena. J Am Anim Hosp Assoc 1980; 16 (1):129135.
  • 18
    Green RA, Kabel AL. Hypercoagulable state in three dogs with nephrotic syndrome: role of acquired antithrombin III deficiency. J Am Vet Med Assoc 1982; 181 (9):914917.
  • 19
    Slauson DO, Gribble DH. Thrombosis complicating renal amyloidosis in dogs. Vet Pathol 1971; 8 (4):352363.
  • 20
    Warren DF, Turner DM, Kelly JD. Post-operative pulmonary embolism in the dog. Aust Vet J 1970; 46 (6):277280.
  • 21
    Suter PF, Ettinger SJ. Miscellaneous diseases of the thorax, In: EttingerSJ. ed. Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat, 1st ed. Philadelphia: WB Saunders Co; 1975, pp. 807822.
  • 22
    Virchow RLK. Cellular Pathology. 1859 special ed. London: John Churchill; 1978, pp. 204207.
  • 23
    Dalen JE. Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology, and diagnosis. Chest 2002; 122 (4):14401456.
  • 24
    Aird WC. Vascular bed-specific thrombosis. J Thromb Haemost 2007; 5 (suppl 1):283291.
  • 25
    Greengard JS, Eichinger S, Griffin JH, et al. Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg–>Gln mutation in the gene for factor V. N Engl J Med 1994; 331 (23):15591562.
  • 26
    Dantzker DR, Wagner PD, Tornabene VW, et al. Gas exchange after pulmonary thromboemoblization in dogs. Circ Res 1978; 42 (1):92103.
  • 27
    Levy SE, Simmons DH. Mechanism of arterial hypoxemia following pulmonary thromboembolism in dogs. J Appl Physiol 1975; 39 (1):4146.
  • 28
    Tisi GM, Wolfe WG, Fallat RJ, et al. Effects of O2 and CO2 on airway smooth muscle following pulmonary vascular occlusion. J Appl Physiol 1970; 28 (5):570573.
  • 29
    Thomas D, Stein M, Tanabe G, et al. Mechanism of bronchoconstriction produced by thromboemboli in dogs. Am J Physiol 1964; 206 (6):12071212.
  • 30
    Austin JH. Intrapulmonary airway narrowing after pulmonary thromboembolism in dogs. Partial control by the parasympathetic nervous system. Invest Radiol 1973; 8 (5):315321.
  • 31
    Giammona ST, Mandelbaum I, Foy J, et al. Effects of pulmonary artery ligation on pulmonary surfactant and pressure-volume characteristics of dog lung. Circ Res 1966; 18 (6):683691.
  • 32
    Chernick V, Hodson WA, Greenfield LJ. Effect of chronic pulmonary artery ligation on pulmonary mechanics and surfactant. J Appl Physiol 1966; 21 (4):13151320.
  • 33
    Finley TH, Swensen EW, Clements JA, et al. Changes in mechanical properties, appearance and surface activity of extracts of one lung following occlusion of its pulmonary artery in the dog. Physiologist 1960; 3 (1):5672.
  • 34
    Dennis JS. The pathophysiologic sequelae of pulmonary thromboembolism. Comp Contin Educ Pract Vet 1991; 13 (12):18111818.
  • 35
    Singer D, Hesser C, Pick R, et al. Diffuse bilateral pulmonary edema associated with unilobar miliary pulmonary embolization in the dog. Circ Res 1958; 6 (1):49.
  • 36
    Malik AB, Van Der Zee H. Mechanism of pulmonary edema induced by microembolization in dogs. Circ Res 1978; 42 (1):7379.
  • 37
    Perlman MB, Johnson A, Jubiz W, et al. Lipoxygenase products induce neutrophil activation and increase endothelial permeability after thrombin-induced pulmonary microembolism. Circ Res 1989; 64 (1):6273.
  • 38
    Fluckiger MA, Gomez JA. Radiographic findings in dogs with spontaneous pulmonary thrombosis or embolism. Vet Radiol 1984; 25 (3):124131.
  • 39
    Dalen JE, Haffajee CI, Alpert JS, et al. Pulmonary-embolism, pulmonary hemorrhage and pulmonary infarction. N Engl J Med 1977; 296 (25):14311435.
  • 40
    Ebert PA, Allgood RJ, Jones HW III, et al. Hemodynamics during pulmonary artery occlusion. Surgery 1967; 62 (1):1824.
  • 41
    West JB. Blood flow and metabolism, In: WestJB. Respiratory Physiology: The Essentials, 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005, pp. 3554.
  • 42
    Halmagyi DF, Starzecki B, Horner GJ. Humoral transmission of cardiorespiratory changes in experimental lung embolism. Circ Res 1964; 14 (6):546554.
  • 43
    Gurewich V, Cohen ML, Thomas DP. Humoral factors in massive pulmonary embolism: an experimental study. Am Heart J 1968; 76 (6):784794.
  • 44
    McGoon MD, Vanhoutte PM. Aggregating platelets contract isolated canine pulmonary arteries by releasing 5-hydroxytryptamine. J Clin Invest 1984; 74 (3):828833.
  • 45
    Snyder LA, Neel JA, Grindem CB. Thrombocytosis in dogs: a retrospective study. Vet Clin Pathol 2007; 36 (3):315.
  • 46
    Feldman BF. Thrombosis – diagnosis and treatment, In: KirkRW. ed. Current Veterinary Therapy IX: Small Animal Practice, 9th ed. Philadelphia: WB Saunders Co.; 1986, pp. 505509.
  • 47
    Schafer AI. Thrombocytosis. N Engl J Med 2004; 350 (12):12111219.
  • 48
    Feldman BF, Kirby R, Caldin M. Recognition and treatment of disseminated intravascular coagulation, In: BonaguraJD. ed. Kirk's Current Veterinary Therapy XIII: Small Animal Practice, 13th ed. Philadelphia: WB Saunders Co.; 2000, pp. 190194.
  • 49
    Maloba M, Hogg K. Best evidence topic report. Diagnostic utility of arterial blood gases for investigation of pulmonary embolus. Emerg Med J 2005; 22 (6):435436.
  • 50
    Cloutier LM. Diagnosis of pulmonary embolism. Clin J Oncol Nurs 2007; 11 (3):343348.
  • 51
    Riedel M. Diagnosing pulmonary embolism. Postgrad Med J 2004; 80 (944):309319.
  • 52
    McIntyre KM, Sasahara AA. The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am J Cardiol 1971; 28 (2):288294.
  • 53
    Hsu JT, Chu CM, Chang ST, et al. Prognostic role of alveolar-arterial oxygen pressure difference in acute pulmonary embolism. Circ J 2006; 70 (12):16111616.
  • 54
    Hsu JT, Chu CM, Chang ST, et al. Prognostic value of arterial/alveolar oxygen tension ratio (a/APO2) in acute pulmonary embolism. Circ J 2007; 71 (10):15601566.
  • 55
    Westermark N. On the roentgen diagnosis of lung embolism. Acta Radiol 1938; 19:357372.
  • 56
    Dennis JS. Clinical features of canine pulmonary thromboembolism. Compendium Continuing Vet Ed 1993; 15 (12):15951603.
  • 57
    Figley MM, Gerdes AJ, Ricketts HJ. Radiographic aspects of pulmonary embolism. Semin Roentgenol 1967; 2 (4):389405.
  • 58
    Keyes ML, Rush JE, Knowles KE. Pulmonary thromboembolism in dogs. J Vet Emerg Crit Care 1993; 3 (1):2332.
  • 59
    Hackner SG. Pulmonary thromboembolism, In: KingLG. ed. Textbook of Respiratory Disease in Dogs and Cats. Philadelphia: WB Saunders Co; 2004, pp. 526541.
  • 60
    Roemisch J, Gray E, Hoffmann JN, et al. Antithrombin: a new look at the actions of a serine protease inhibitor. Blood Coagul Fibrinolysis 2002; 13 (8):657670.
  • 61
    Bick RL. Clinical relevance of antithrombin III. Semin Thromb Hemost 1982; 8 (4):276287.
  • 62
    Green RA. Pathophysiology of antithrombin III deficiency. Vet Clin North Am Small Anim Pract 1988; 18 (1):95104.
  • 63
    Nelson OL, Andreasen C. The utility of plasma D-dimer to identify thromboembolic disease in dogs. J Vet Intern Med 2003; 17 (6):830834.
  • 64
    Stokol T. Plasma D-dimer for the diagnosis of thromboembolic disorders in dogs. Vet Clin North Am Small Anim Pract 2003; 33 (6):14191435.
  • 65
    Scott-Moncrieff JC, Treadwell NG, McCullough SM, et al. Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia. J Am Anim Hosp Assoc 2001; 37 (3):220227.
  • 66
    Boisvert AM, Swenson CL, Haines CJ. Serum and plasma latex agglutination tests for detection of fibrin(ogen) degradation products in clinically ill dogs. Vet Clin Pathol 2001; 30 (3):133136.
  • 67
    Stokol T, Brooks MB, Erb HN, et al. D-dimer concentrations in healthy dogs and dogs with disseminated intravascular coagulation. Am J Vet Res 2000; 61 (4):393398.
  • 68
    Stein PD, Woodard PK, Weg JG, et al. Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators. Radiology 2007; 242 (1):1521.
  • 69
    Griffin A, Callan MB, Shofer FS, et al. Evaluation of a canine D-dimer point-of-care test kit for use in samples obtained from dogs with disseminated intravascular coagulation, thromboembolic disease, and hemorrhage. Am J Vet Res 2003; 64 (12):15621569.
  • 70
    Ben S, Ni S, Shen H, et al. The dynamic changes of LDH isoenzyme 3 and D-dimer following pulmonary thromboembolism in canine. Thromb Res 2007; 120 (4):575583.
  • 71
    Callan MB, Aljamali MN, Margaritis P, et al. A novel missense mutation responsible for factor VII deficiency in research Beagle colonies. J Thromb Haemost 2006; 4 (12):26162622.
  • 72
    Donahue SM, Otto CM. Thromboelastography: a tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis. J Vet Emerg Crit Care 2005; 15 (1):916.
  • 73
    Brainard BM, Meredith CP, Callan MB, et al. Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs. Am J Vet Res 2007; 68 (3):251257.
  • 74
    Varon D, Savion N. Impact cone and plate(let) analyzer, In: MichelsonAD. ed. Platelets. Amsterdam: Elsevier; 2007, pp. 535544.
  • 75
    Hartert H. Blutgerinnungsstudien mit der thrombelastographie, einem neuen untersuchungsverfahren. Klinische Wochenschrift 1948; 26 (37–38):577583.
  • 76
    Kang Y, Marquez D, Lewis J, et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 1985; 64 (9):888896.
  • 77
    Shore-Lesserson L, Manspeizer H, De Perio M, et al. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88 (2):312319.
  • 78
    Sorensen B, Ingerslev J. Whole blood clot formation phenotypes in haemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J Thromb Haem 2004; 2 (1):102110.
  • 79
    Handa A, Cox D, Hamilton G, Pasi K, et al. Thrombelastography: an effective screening test for prothrombotic states. Thromb Haem 1997; 78 (S1):440.
  • 80
    O'Donnell J, Riddell A, Owens D, et al. Role of the thrombelastograph as an adjunctive test in thrombophilia screening. Blood Coag Fibrinol 2004; 15 (3):207211.
  • 81
    Steib A, Gengenwin N, Freys G, et al. Predictive factors of hyperfibrinolytic activity during liver transplantation in cirrhotic patients. Br J Anaesth 1994; 73 (5):645648.
  • 82
    Wiinberg B, Jensen AL, Rojkjaer R, et al. Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Vet Clin Pathol 2005; 34 (4):389393.
  • 83
    Alwood AJ, Downend AB, Brooks MB, et al. Anticoagulant effects of low-molecular-weight heparins in healthy cats. J Vet Intern Med 2007; 21 (3):378387.
  • 84
    Montgomery A, Couto CG, Schober K, et al. Thromboelastography in healthy cats. J Vet Intern Med 2008; 22 (3):774.
  • 85
    Bjornvad CR, Wiinberg B, Jensen AL, et al. Evaluation of tissue factor and kaolin activated thromboelastography on feline citrated whole blood from clinically healthy cats. J Vet Intern Med 2008; 22 (3):739.
  • 86
    Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27 (2):8190.
  • 87
    Nielsen VG. A comparison of the thrombelastograph and the ROTEM. Blood Coagul Fibrinolysis 2007; 18 (3):247252.
  • 88
    Alwood AJ, Downend AB, Slensky KA, et al. Evaluation of thromboelastography (TEG) in normal cats. J Vet Emerg Crit Care 2004; 14 (S1):S1.
  • 89
    McCrath DJ, Cerboni E, Frumento RJ, et al. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005; 100 (6):15761583.
  • 90
    Otto CM, Rieser TM, Brooks MB, et al. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000; 217 (10):15001504.
  • 91
    Kristensen AT, Wiinberg B, Jessen LR, et al. Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia. J Vet Intern Med 2008; 22 (1):140147.
  • 92
    Wiinberg B, Jensen AL, Johansson PI, et al. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med 2008; 22 (2):357365.
  • 93
    Dalen JE, Mathur VS, Evans H, et al. Pulmonary angiography in experimental pulmonary embolism. Am Heart J 1966; 72 (4):509520.
  • 94
    Bookstein JJ, Silver TM. The angiographic differential diagnosis of acute pulmonary embolism. Radiology 1974; 110 (1):2533.
  • 95
    Henderson RA, Dillon AR, Brawner WR, et al. Technique for percutaneous pulmonary arterial catheterization in conscious dogs. Am J Vet Res 1985; 46 (7):15381539.
  • 96
    Newman GE. Pulmonary angiography in pulmonary embolic disease. J Thorac Imag 1989; 4 (4):2839.
  • 97
    Cornelissen JMM, Wolvekamp WTC, Stokhof AA, et al. Primary occlusive pulmonary vascular-disease in a dog diagnosed by a lung perfusion scintigram. J Am Anim Hosp Assoc 1985; 21 (2):293299.
  • 98
    Miller MS, Tilley LP, Calvert CA. Electrocardiographic correlations in pulmonary heart disease. Semin Vet Med Surg (Small Anim) 1986; 1 (4):331337.
  • 99
    Goldhaber SZ. Echocardiography in the management of pulmonary embolism. Ann Int Med 2002; 136 (9):691700.
  • 100
    Nazeyrollas P, Metz D, Chapoutot L, et al. Diagnostic accuracy of echocardiography-Doppler in acute pulmonary embolism. Int J Cardiol 1995; 47 (3):273280.
  • 101
    Kasper W, Meinertz T, Henkel B, et al. Echocardiographic findings in patients with proved pulmonary-embolism. Am Heart J 1986; 112 (6):12841290.
  • 102
    Ribeiro A, Lindmarker P, JuhlinDannfelt A, et al. Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J 1997; 134 (3):479487.
  • 103
    Goldhaber SZ, Visani L, De Rosa M, et al. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353 (9162):13861389.
  • 104
    Kasper W, Konstantinides S, Geibel A, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997; 30 (5):11651171.
  • 105
    Torbicki A, Van Beek EJR, Charbonnier B, et al. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 2000; 21 (16):13011336.
  • 106
    Ribeiro A, Juhlin-Dannfelt A, Brodin LA, et al. Pulmonary embolism: relation between the degree of right ventricle overload and the extent of perfusion defects. Am Heart J 1998; 135 (5):868874.
  • 107
    McConnell MV, Solomon SD, Rayan ME, et al. Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol 1996; 78 (4):469473.
  • 108
    Chetboul V, Sampedrano CC, Gouni V, et al. Ultrasonographic assessment of regional radial and longitudinal systolic function in healthy awake dogs. J Vet Intern Med 2006; 20 (4):885893.
  • 109
    Venco L, Calzolari D, Morini S. Pulmonary thromboembolism in a dog with renal amyloidosis. Vet Radiol Ultrasound 1998; 39 (6):564565.
  • 110
    Schober KE. Biochemical markers of cardiovascular disease, In: EttingerSJ, FeldmanEC. eds. Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat, 6th ed. Philadelphia: Elsevier Saunders; 2005, pp. 940948.
  • 111
    Ricchiuti V, Sharkey SW, Murakami MM, et al. Cardiac troponin I and T alterations in dog hearts with myocardial infarction: correlation with infarct size. Am J Clin Pathol 1998; 110 (2):241247.
  • 112
    Schober KE, Cornand C, Kirbach B, et al. Serum cardiac troponin I and cardiac troponin T concentrations in dogs with gastric dilatation-volvulus. J Am Vet Med Assoc 2002; 221 (3):381388.
  • 113
    Lobetti R, Dvir E, Pearson J. Cardiac troponins in canine babesiosis. J Vet Intern Med 2002; 16 (1):6368.
  • 114
    Janata K, Holzer M, Laggner AN, et al. Cardiac troponin T in the severity assessment of patients with pulmonary embolism: cohort study. Br Med J 2003; 326 (7384):312313.
  • 115
    Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism – a meta-analysis. Circulation 2007; 116 (4):427433.
  • 116
    Alderson PO, Doppman JL, Diamond SS, et al. Ventilation–perfusion lung imaging and selective pulmonary angiography in dogs with experimental pulmonary embolism. J Nucl Med 1978; 19 (2):164171.
  • 117
    Koblik PD, Hornof W, Harnagel SH, et al. A comparison of pulmonary angiography, digital subtraction angiography, and 99mTc-DTPA/MAA ventilation–perfusion scintigraphy for detection of experimental pulmonary emboli in the dog. Vet Radiol 1989; 30 (4):159168.
  • 118
    Pouchelon JL, Chetboul V, Devauchelle P, et al. Diagnosis of pulmonary thromboembolism in a cat using echocardiography and pulmonary scintigraphy. J Small Anim Pract 1997; 38 (7):306310.
  • 119
    Daniel GB, Berry CR. Pulmonary and mucociliary scintigraphy, In: BerryCR, DanielGB. eds. Textbook of Veterinary Nuclear Medicine, 2nd ed. Harrisburg, PA: American College of Veterinary Radiology; 2006, pp. 304327.
  • 120
    Remy-Jardin M, Remy J, Wattinne L, et al. Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the single-breath-hold technique–comparison with pulmonary angiography. Radiology 1992; 185 (2):381387.
  • 121
    Gurney JW. No fooling around: direct visualization of pulmonary embolism. Radiology 1993; 188 (3):618619.
  • 122
    Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 2006; 354 (22):23172327.
  • 123
    Sinner WN. Computed tomographic patterns of pulmonary thromboembolism and infarction. J Comput Assist Tomogr 1978; 2 (4):395399.
  • 124
    Goodman LR, Curtin JJ, Mewissen MW, et al. Detection of pulmonary embolism in patients with unresolved clinical and scintigraphic diagnosis: helical CT versus angiography. Am J Roentgenol 1995; 164 (6):13691374.
  • 125
    Rathbun SW, Raskob GE, Whitsett TL. Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review. Ann Intern Med 2000; 132 (3):227232.
  • 126
    Mullins MD, Becker DM, Hagspiel KD, et al. The role of spiral volumetric computed tomography in the diagnosis of pulmonary embolism. Arch Intern Med 2000; 160 (3):293298.
  • 127
    The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). J Am Med Assoc 1990; 263 (20):27532759.
  • 128
    American College of Emergency Physicians Clinical Policies Committee; Clinical Policies Committee Subcommittee on Suspected Pulmonary Embolism. Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected pulmonary embolism. Ann Emerg Med 2003; 41 (2):257270.
  • 129
    British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group. Thorax 2003; 58 (6):470483.
  • 130
    Schoepf UJ, Costello P. CT angiography for diagnosis of pulmonary embolism: state of the art. Radiology 2004; 230 (2):329337.
  • 131
    Quiroz R, Kucher N, Zou KH, et al. Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism: a systematic review. J Am Med Assoc 2005; 293 (16):20122017.
  • 132
    Perrier A, Roy PM, Sanchez O, et al. Multidetector-row computed tomography in suspected pulmonary embolism. N Engl J Med 2005; 352 (17):17601768.
  • 133
    Frank P, Mahaffey M, Egger C, et al. Helical computed tomographic portography in ten normal dogs and ten dogs with a portosystemic shunt. Vet Radiol Ultrasound 2003; 44 (4):392400.
  • 134
    Zwingenberger AL, Schwarz T. Dual-phase CT angiography of the normal canine portal and hepatic vasculature. Vet Radiol Ultrasound 2004; 45 (2):117124.
  • 135
    Zwingenberger AL, Schwarz T, Saunders HM. Helical computed tomographic angiography of canine portosystemic shunts. Vet Radiol Ultrasound 2005; 46 (1):2732.
  • 136
    Tidwell SA, Graham JP, Peck JN, et al. Incidence of pulmonary embolism after non-cemented total hip arthroplasty in eleven dogs: computed tomographic pulmonary angiography and pulmonary perfusion scintigraphy. Vet Surg 2007; 36 (1):3742.
  • 137
    Kirberger RM, Zambelli A. Imaging diagnosis – aortic thromboembolism associated with spirocercosis in a dog. Vet Radiol Ultrasound 2007; 48 (5):418420.
  • 138
    Van Beek EJ, Wild JM, Fink C, et al. MRI for the diagnosis of pulmonary embolism. J Magn Reson Imaging 2003; 18 (6):627640.
  • 139
    Hurst DR, Kazerooni EA, Stafford-Johnson D, et al. Diagnosis of pulmonary embolism: comparison of CT angiography and MR angiography in canines. J Vasc Interv Radiol 1999; 10 (3):309318.
  • 140
    Moody AR, Liddicoat A, Krarup K. Magnetic resonance pulmonary angiography and direct imaging of embolus for the detection of pulmonary emboli. Invest Radiol 1997; 32 (8):431440.
  • 141
    Morris TA, Marsh JJ, Chiles PG, et al. Single photon emission computed tomography of pulmonary emboli and venous thrombi using anti-D-dimer. Am J Respir Crit Care Med 2004; 169 (9):987993.
  • 142
    Sanson BJ, Lijmer JG, Mac Gillavry MR, et al. Comparison of a clinical probability estimate and two clinical models in patients with suspected pulmonary embolism. ANTELOPE-Study Group. Thromb Haemost 2000; 83 (2):199203.
  • 143
    Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000; 83 (3):416420.
  • 144
    Chagnon I, Bounameaux H, Aujesky D, et al. Comparison of two clinical prediction rules and implicit assessment among patients with suspected pulmonary embolism. Am J Med 2002; 113 (4):269275.
  • 145
    Nelson OL. Use of the D-dimer assay for diagnosing thromboembolic disease in the dog. J Am Anim Hosp Assoc 2005; 41 (3):145149.
  • 146
    Goldhaber SZ. Deep vein thrombosis and pulmonary embolism, In: KitchensCS, AlvingBM, KesslerCM. eds. Consultative Hemostasis and Thrombosis, 2nd ed. Philadelphia: WB Saunders Co; 2007, pp. 245256.
  • 147
    Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med 1992; 326 (19):12401245.
  • 148
    Thorpe PE. The role of thrombolytic therapy in pulmonary embolism. Tech Vasc Interv Radiol 1998; 1 (4):199208.
  • 149
    Carlbom DJ, Davidson BL. Pulmonary embolism in the critically ill. Chest 2007; 132 (1):313324.
  • 150
    Hirsch LJ, Rooney MW, Wat SS, et al. Norepinephrine and phenylephrine effects on right ventricular function in experimental canine pulmonary embolism. Chest 1991; 100 (3):796801.
  • 151
    Pascoe PJ, Ilkiw JE, Pypendop BH. Effects of increasing infusion rates of dopamine, dobutamine, epinephrine, and phenylephrine in healthy anesthetized cats. Am J Vet Res 2006; 67 (9):14911499.
  • 152
    Hofmeister EH, Keenan K, Egger CM. Dobutamine-induced bradycardia in a dog. Vet Anaesthesia Analgesia 2005; 32 (2):107111.
  • 153
    Tanus-Santos JE, Theodorakis MJ. Is there a place for inhaled nitric oxide in the therapy of acute pulmonary embolism? Am J Respir Med 2002; 1 (3):167176.
  • 154
    Griffiths MJ, Evans TW. Inhaled nitric oxide therapy in adults. N Engl J Med 2005; 353 (25):26832695.
  • 155
    Bach JF, Rozanski EA, MacGregor J, et al. Retrospective evaluation of sildenafil citrate as a therapy for pulmonary hypertension in dogs. J Vet Intern Med 2006; 20 (5):11321135.
  • 156
    Kellum HB, Stepien RL. Sildenafil citrate therapy in 22 dogs with pulmonary hypertension. J Vet Intern Med 2007; 21 (6):12581264.
  • 157
    Dias-Junior CA, Souza-Costa DC, Zerbini T, et al. The effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension. Anesth Analg 2005; 101 (1):115120.
  • 158
    Dias-Junior CA, Vieira TF, Moreno H Jr, et al. Sildenafil selectively inhibits acute pulmonary embolism-induced pulmonary hypertension. Pulm Pharmacol Ther 2005; 18 (3):181186.
  • 159
    Souza-Silva AR, Dias-Junior CA, Uzuelli JA, et al. Hemodynamic effects of combined sildenafil and l-arginine during acute pulmonary embolism-induced pulmonary hypertension. Eur J Pharmacol 2005; 524 (1–3):126131.
  • 160
    Dias-Junior CA, Tanus-Santos JE. Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism. Life Sci 2006; 79 (5):469474.
  • 161
    Ganiere V, Feihl F, Tagan D. Dramatic beneficial effects of sildenafil in recurrent massive pulmonary embolism. Intensive Care Med 2006; 32 (3):452454.
  • 162
    Bresser P, Pepke-Zaba J, Jaïs X, et al. Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm. Proc Am Thorac Soc 2006; 3 (7):594600.
  • 163
    Patel SC, Mody A Cerebral hemorrhagic complications of thrombolytic therapy. Prog Cardiovas Dis 1999; 42 (3):217233.
  • 164
    Vanscoy GJ, Rihn TL, Koerner PH. Tenecteplase: innovative fibrinolysis for ST segment elevation myocardial infarction (STEMI). Pharm Ther 2003; 28 (1):2030.
  • 165
    Arcasoy SM, Kreit JW Thrombolytic therapy of pulmonary embolism. Chest 1999; 115 (6):16951707.
  • 166
    Moore KE, Morris N, Dhupa N, et al. Retrospective study of streptokinase administration in 46 cats with arterial thromboembolism. J Vet Emerg Crit Care 2000; 10 (4):245257.
  • 167
    Pion PD. Feline aortic thromboemboli and the potential utility of thrombolytic therapy with tissue plasminogen activator. Vet Clin North Am Small Anim Pract 1988; 18 (1):7986.
  • 168
    Ramsey CC, Burney DP, Macintire DK, et al. Use of streptokinase in four dogs with thrombosis. J Am Vet Med Assoc 1996; 209 (4):780785.
  • 169
    Whelan MF, O'Toole TE. The use of thrombolytic agents. Comp Contin Edu Prac Vet 2007; 29 (8):476482.
  • 170
    Marjerus PW, Broze GJ Jr, Miletich JP, et al. Anticoagulant, thrombolytic, and antiplatelet drugs, In: HardmanJG, LimbirdLE, MolinoffPB, et al., eds. Goodman and Gilman's the Pharmacologic Basis of Therapeutics, 9th ed. New York: McGraw-Hill; 1996, pp. 13411359.
  • 171
    Whelan MF, O'Toole TE, Chan DL, et al. Retrospective evaluation of urokinase use in cats with arterial thromboembolism. J Vet Emerg Crit Care 2005; 15 (S1):S8.
  • 172
    Haberstroh J, Wagner G, Kiefer T, et al. Renal artery occlusion model in dogs for the evaluation of thrombolytic agents. J Invest Surg 1997; 10 (4):183188.
  • 173
    Maki A, Shirato C, Ohguchi M, Aoki N, et al. Mechanism of rethrombosis after thrombolytic therapy: angioscopic findings and investigation of the coagulation system in dogs. Angiology 1998; 49 (6):447453.
  • 174
    Rhodes JM, Cho JS, Gloviczki P, et al. Thrombolysis for experimental deep venous thrombosis maintains valvular competence and vasoreactivity. J Vasc Surg 2000; 31 (6):11931205.
  • 175
    Whelan MF, O'Toole TE, Chan DL, et al. Retrospective evaluation of urokinase use in dogs with thromboembolism (4 cases): 2003–2004). J Vet Emerg Crit Care 2005; 15 (S1):S8.
  • 176
    Marder VJ. Thrombolytic therapy, In: KitchensCS, AlvingBM, KesslerCM. eds. Consultative Hemostasis and Thrombosis, 2nd ed. Philadelphia: WB Saunders Co; 2007, pp. 491502.
  • 177
    Longstaff C, Thelwell C. Understanding the enzymology of fibrinolysis and improving thrombolytic therapy. FEBS Lett 2005; 579 (15):33033309.
  • 178
    Clare AC, Kraje BJ. Use of recombinant tissue-plasminogen activator for aortic thrombolysis in a hypoproteinemic dog. J Am Vet Med Assoc 1998; 212 (4):539543.
  • 179
    Shiffman F, Ducas J, Hollett P, et al. Treatment of canine pulmonary hypertension with recombinant tissue plasminogen activator. Circulation 1988; 78 (1):214220.
  • 180
    Lunsford KV, Mackin AJ. Thromboembolic therapies in dogs and cats: an evidence-based approach. Vet Clin Small Anim 2007; 37 (3):579609.
  • 181
    Buller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3, suppl):401S428S.
  • 182
    Kucher N, Rossi E, De Rosa M, et al. Massive pulmonary embolism. Circulation 2006; 113 (4):577582.
  • 183
    Morris TA, Marsh JJ, Chiles PG, et al. Embolization itself stimulates thrombus propagation in pulmonary embolism. Am J Physiol Heart Circ Physiol 2004; 287 (2):H818H822.
  • 184
    Watson HG, Chee YL. Aspirin and other antiplatelet drugs in the prevention of venous thromboembolism. Blood Rev 2008; 22 (2):107116.
  • 185
    Hurlen M, Abdelnoor M, Smith P, et al. Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 2002; 347 (13):969974.
  • 186
    Schulman S, Lindmarker P, Holmstrom M, et al. Postthrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost 2006; 4 (4):734742.
  • 187
    Buller HR, Davidson BL, Decousus H, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003; 349 (18):16951702.
  • 188
    Eriksson UG, Bredberg U, Hoffmann KJ, et al. Absorption, distribution, metabolism, and excretion of ximelagatran an oral direct thrombin inhibitor, in rats, dogs, and humans. Drug Metab Disp 2003; 31 (3):294305.
  • 189
    Mattson C, Bjorkman JA, Abrahamsson T, et al. Local proCPU (TAFI) activation during thrombolytic treatment in a dog model of coronary artery thrombosis can be inhibited with a direct, small molecule thrombin inhibitor (melagatran). Thromb Haemost 2002; 87 (4):557562.
  • 190
    Hirsh J, Raschke R. Heparin and low molecular weight heparins: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3, suppl):188S203S.
  • 191
    Casu B, Oreste P, Torri G, et al. The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Biochem J 1981; 197 (3):599609.
  • 192
    Ofosu FA, Hirsh J, Esmon CT, et al. Unfractionated heparin inhibits thrombin-catalyzed amplification reactions of coagulation more efficiently than those catalyzed by factor Xa. Biochem J 1989; 257 (1):143150.
  • 193
    Ofosu FA, Sie P, Modi GJ, et al. The inhibition of thrombin-dependent feedback reactions is critical to the expression of anticoagulant effects of heparin. Biochem J 1987; 243 (2):579588.
  • 194
    Beguin S, Lindhout T, Hemker HC. The mode of action of heparin in plasma. Thromb Haemost 1988; 60 (3):457462.
  • 195
    Mischke RH, Schuttert C, Grebe SI. Anticoagulant effects of repeated subcutaneous injections of high doses of unfractionated heparin in healthy dogs. Am J Vet Res 2001; 62 (12):18871891.
  • 196
    Green RA. Activated partial thromboplastin time in monitoring heparinized dogs. Am J Vet Res 1980; 11:17931797.
  • 197
    Hellebrekers LJ, Slappendel RJ, Van Den Brom WE. Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog. Am J Vet Res 1985; 46:14601462.
  • 198
    Raschke RA, Reilly BM, Guidry JR, et al. The weight-based heparin dosing nomogram compared with a “standard care” nomogram. A randomized controlled trial. Ann Intern Med 1993; 119 (9):874881.
  • 199
    Harenberg J. Pharmacology of low molecular weight heparins. Semin Thromb Hemost 1990; 16 (suppl):1218.
  • 200
    Handeland GF, Abildgaard GF, Holm U, et al. Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin. Eur J Clin Pharmacol 1990; 39 (2):107112.
  • 201
    Lunsford K, Mackin A, Langston VC, et al. Pharmacokinetics of the biological effects of subcutaneously administered enoxaparin, a low molecular weight heparin, in dogs. J Vet Intern Med 2005; 19 (3):401.
  • 202
    Mischke R, Grebe S, Jacobs C, et al. Amidolytic heparin activity and values for several hemostatic variables after repeated subcutaneous administration of high doses of a low molecular weight heparin in healthy dogs. Am J Vet Res 2001; 62 (4):595598.
  • 203
    Grebe S, Jacobs C, Kietzmann M, et al. Pharmacokinetics of low-molecular-weight heparins Fragmin D in dogs. Berl Munch Tierarztl Wochenschr 2000; 113 (3):103107.
  • 204
    Bauer KA, Hawkins DW, Peters PC, et al. Fondaparinux, a synthetic pentasaccharide: the first in a new class of antithrombotic agents - the selective factor Xa inhibitors. Cardiovasc Drug Rev 2002; 20 (1):3752.
  • 205
    Ansell J, Hirsh J, Poller L, et al. The pharmacology and management of vitamin K antagonists: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126 (3, suppl):204S233S.
  • 206
    Hirsh J, O'Donnell M, Eikelboom JW. Beyond unfractionated heparin and warfarin: current and future advances. Circulation 2007; 116 (5):552560.
  • 207
    Turpie AG. New oral anticoagulants in atrial fibrillation. Eur Heart J 2007; 29 (2):155165.
  • 208
    Bauer KA. New anticoagulants. Hematology Am Soc Hematol Educ Program 2006; 1:450456.
  • 209
    Fasco MJ, Hildebrandt EF, Suttie JW. Evidence that warfarin anticoagulant action involves two distinct reductase activities. J Biol Chem 1982; 257 (19):1121011212.
  • 210
    Nelsestuen GL, Zytkovicz TH, Howard JB. The mode of action of vitamin K: identification of γ-carboxyglutamic acid as a component of prothrombin. J Biol Chem 1974; 249 (19):63476350.
  • 211
    Hirsh J, Dalen JE, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001; 119 (suppl):8S21S.
  • 212
    Nelsestuen GL. Role of gamma-carboxyglutamic acid: an unusual transition required for calcium-dependent binding of prothrombin to phospholipid. J Biol Chem 1976; 251 (18):56485656.
  • 213
    Borowski M, Furie BC, Bauminger S, et al. Prothrombin requires two sequential metal-dependent conformational transitions to bind phospholipid. J Biol Chem 1986; 261 (32):1496914975.
  • 214
    Kirkwood TB. Calibration of reference thromboplastins and standardisation of the prothrombin time ratio. Thromb Haemost 1983; 49 (3):238244.
  • 215
    Monnet E, Morgan MR. Effect of three loading doses of warfarin on the international normalized ratio for dogs. Am J Vet Res 2000; 61 (1):4850.
  • 216
    Smith SA. Warfarin treatment in small animal patients [abstract]. Proceedings of the 16th Annual ACVIM Forum, American College of Veterinary Internal Medicine, San Diego, 1998. p. 440.
  • 217
    Orton EC, Hackett TB, Mama K, et al. Technique and outcome of mitral valve replacement in dogs. J Am Vet Med Assoc 2005; 226 (9):15081511.
  • 218
    Hoffman M, Monroe DM 3rd. A cell-based model of hemostasis. Thromb Haemost 2001; 85 (6):958965.
  • 219
    Hogan DF, Andrews DA, Talbott KK, et al. Evaluation of antiplatelet effects of ticlopidine in cats. Am J Vet Res 2004; 65 (3):327332.
  • 220
    Weinkle TK, Center SA, Randolph JF, et al. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993–2002). J Am Vet Med Assoc 2005; 226 (11):18691880.
  • 221
    Hogan DF. Interim analysis from the fat cat study on arterial thromboembolism. Proceedings ACVIM 25th Annual Forum, Seattle, WA, 2007.
  • 222
    Bright JM, Dowers K, Powers BE. Effects of the glycoprotein IIb/IIIa antagonist abciximab on thrombus formation and platelet function in cats with arterial injury. Vet Ther 2003; 4 (1):3546.
  • 223
    Bright JM, Dowers K, Hellyer P. In vitro antiaggregatory effects of GP IIb/IIIa antagonist eptifibatide on feline platelets. J Vet Intern Med 2002; 6:16:v (letter).
  • 224
    Hylands R. Veterinary diagnostic imaging. Can Vet J 2006; 47 (4):385388.
  • 225
    Cipollone F, Patrignani P, Greco A, et al. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation 1997; 96 (4):11091116.
  • 226
    Preston FE, Whipps S, Jackson CA, et al. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. N Engl J Med 1981; 304 (2):7679.
  • 227
    Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest 1982; 69 (6):13661372.
  • 228
    Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 1994; 330 (18):12871294.
  • 229
    Smith SA, Tobias AH, Jacob KA, et al. Arterial thromboembolism in cats: acute crisis in 127 cases (1992–2001) and long-term management with low-dose aspirin in 24 cases. J Vet Intern Med 2003; 17 (1):7383.
  • 230
    Boudreaux MK, Dillon AR, Ravis WR, et al. Effects of treatment with aspirin or aspirin/dipyridamole combination in heartworm-negative, heartworm-infected, and embolized heartworm infected dogs. Am J Vet Res 1991; 52 (12):19921999.
  • 231
    Tarish JH, Atwell RB. The effect of prostaglandin inhibition on the development of pulmonary pathology associated with dead Dirofilaria immitis. Vet Parasitol 1993; 49 (2–4):207217.
  • 232
    2005 guidelines for the diagnosis, prevention and management of heartworm (Dirofilaria immitis) infection in dogs. American Heartworm Society Available at: 10-08-08.
  • 233
    Grauer GF. CVT update: canine glomerulonephritis, In: BonaguraJD. ed. Kirk's Current Veterinary Therapy XIII. Philadelphia: WB Saunders Co; 2000, pp. 851853.
  • 234
    Born G, Patrono C. Antiplatelet drugs. Br J Pharmacol 2006; 147 (suppl 1):S241S251.
  • 235
    Patrono C, Coller B, Fitzgerald GA, et al. Platelet-active drugs: the relationships among dose, effectiveness, and side effects. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126 (3, suppl):234S264S.
  • 236
    Hogan DF, Andrews DA, Green HW, et al. Antiplatelet effects and pharmacodynamics of clopidogrel in cats. J Am Vet Med Assoc 2004; 225 (9):14061411.
  • 237
  • 238
    DeFranscesco R. Refractory heart failure. Proceedings IVECCS, San Antonio, TX, 2006.
  • 239
    Ware WA. Cardiovascular Disease in Small Animal Medicine, 1st ed. London: Manson Publishing; 2007, p. 172.
  • 240
    Ramsey I. BSAVA Formulary, 6th ed. Quedgeley: BSAVA Publishing; 2008, pp. 1415.
  • 241
    Macintire DK, Drobatz KJ, Haskins SC, et al. Manual of Small Animal Emergency and Critical Care Medicine, 1st ed. Philadelphia: Lippincott, Williams & Wilkins; 2005, p. 439.
  • 242
    Macintire DK, Drobatz KJ, Haskins SC, et al. Manual of Small Animal Emergency and Critical Care Medicine, 1st ed. Philadelphia: Lippincott, Williams & Wilkins; 2005, p. 456.
  • 243
    Smith SA, Lewis DC, Kellerman DL. Adjustment of intermittent subcutaneous heparin therapy based on chromogenic heparin assay in 9 cats with thromboembolic disease. J Vet Intern Med 1998; 12:200.
  • 244
    Kellerman DL, Lewis DC, Bruyette DS, et al. Determination and monitoring of a therapeutic heparin dosage in the dog. J Vet Intern Med 1995; 9:187.